SciSparc (SPRC) Competitors $0.29 -0.03 (-8.28%) Closing price 05/21/2025 03:58 PM EasternExtended Trading$0.31 +0.01 (+4.17%) As of 06:07 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock SPRC vs. UPXI, MBRX, NRSN, INAB, FLGC, BCDA, GOVX, EQ, EDSA, and LPTXShould you be buying SciSparc stock or one of its competitors? The main competitors of SciSparc include Upexi (UPXI), Moleculin Biotech (MBRX), NeuroSense Therapeutics (NRSN), IN8bio (INAB), Flora Growth (FLGC), BioCardia (BCDA), GeoVax Labs (GOVX), Equillium (EQ), Edesa Biotech (EDSA), and Leap Therapeutics (LPTX). These companies are all part of the "pharmaceutical products" industry. SciSparc vs. Upexi Moleculin Biotech NeuroSense Therapeutics IN8bio Flora Growth BioCardia GeoVax Labs Equillium Edesa Biotech Leap Therapeutics Upexi (NASDAQ:UPXI) and SciSparc (NASDAQ:SPRC) are both small-cap business services companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, earnings, community ranking, media sentiment, risk, analyst recommendations, institutional ownership and dividends. Which has stronger earnings and valuation, UPXI or SPRC? SciSparc has lower revenue, but higher earnings than Upexi. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioUpexi$16.56M1.10-$23.66MN/AN/ASciSparc$1.31M2.44-$5.12MN/AN/A Does the media refer more to UPXI or SPRC? In the previous week, Upexi had 2 more articles in the media than SciSparc. MarketBeat recorded 2 mentions for Upexi and 0 mentions for SciSparc. Upexi's average media sentiment score of 0.69 beat SciSparc's score of 0.00 indicating that Upexi is being referred to more favorably in the media. Company Overall Sentiment Upexi Positive SciSparc Neutral Is UPXI or SPRC more profitable? Company Net Margins Return on Equity Return on Assets UpexiN/A N/A N/A SciSparc N/A N/A N/A Does the MarketBeat Community prefer UPXI or SPRC? Upexi received 1 more outperform votes than SciSparc when rated by MarketBeat users. However, 66.67% of users gave SciSparc an outperform vote while only 42.86% of users gave Upexi an outperform vote. CompanyUnderperformOutperformUpexiOutperform Votes342.86% Underperform Votes457.14% SciSparcOutperform Votes266.67% Underperform Votes133.33% Do institutionals and insiders have more ownership in UPXI or SPRC? 5.7% of Upexi shares are held by institutional investors. Comparatively, 25.1% of SciSparc shares are held by institutional investors. 31.6% of Upexi shares are held by insiders. Comparatively, 1.5% of SciSparc shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Which has more volatility and risk, UPXI or SPRC? Upexi has a beta of -0.27, indicating that its share price is 127% less volatile than the S&P 500. Comparatively, SciSparc has a beta of 0.75, indicating that its share price is 25% less volatile than the S&P 500. SummaryUpexi and SciSparc tied by winning 5 of the 10 factors compared between the two stocks. Get SciSparc News Delivered to You Automatically Sign up to receive the latest news and ratings for SPRC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SPRC vs. The Competition Export to ExcelMetricSciSparcPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.19M$6.53B$5.38B$8.39BDividend YieldN/A2.65%5.21%4.10%P/E RatioN/A8.9226.8019.71Price / Sales2.44252.24389.55117.28Price / CashN/A65.8538.2534.62Price / Book0.026.466.804.50Net Income-$5.12M$143.98M$3.23B$248.18M7 Day Performance-3.66%2.03%1.53%0.23%1 Month Performance7.32%4.11%10.05%12.39%1 Year Performance-74.81%-2.87%16.75%7.07% SciSparc Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SPRCSciSparc0.6279 of 5 stars$0.29-8.3%N/A-75.0%$3.19M$1.31M0.004Gap DownUPXIUpexi0.7667 of 5 stars$10.64+7.4%N/A+36.0%$15.17M$18.63M0.00130Earnings ReportHigh Trading VolumeMBRXMoleculin Biotech1.9585 of 5 stars$1.08+2.9%$6.00+455.6%-80.4%$15.12MN/A0.0020NRSNNeuroSense Therapeutics2.4447 of 5 stars$1.10+5.4%N/A+19.0%$15.03MN/A-1.7210INABIN8bio3.2045 of 5 stars$0.16+3.6%$6.00+3,581.0%-87.5%$14.80MN/A-0.2220FLGCFlora Growth2.4992 of 5 stars$0.75+10.5%$5.00+566.7%-47.5%$14.58M$59.51M-0.57280Gap DownBCDABioCardia2.5598 of 5 stars$2.84-0.4%$25.00+780.3%-69.1%$14.47M$58,000.00-0.6840GOVXGeoVax Labs2.1579 of 5 stars$0.93-0.3%$11.10+1,099.9%-39.1%$14.06M$5.59M-0.2510EQEquillium2.6318 of 5 stars$0.39-0.1%$3.00+669.2%-74.5%$13.93M$41.10M-2.7940EDSAEdesa Biotech2.8432 of 5 stars$1.98-3.4%$21.00+960.6%-55.7%$13.91MN/A-1.0620Gap DownLPTXLeap Therapeutics2.4371 of 5 stars$0.38+12.0%$4.92+1,210.8%-85.6%$13.88MN/A-0.1940Positive News Related Companies and Tools Related Companies UPXI Alternatives MBRX Alternatives NRSN Alternatives INAB Alternatives FLGC Alternatives BCDA Alternatives GOVX Alternatives EQ Alternatives EDSA Alternatives LPTX Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SPRC) was last updated on 5/22/2025 by MarketBeat.com Staff From Our PartnersJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThe Secret Map of America, Declassified…Locked inside a Maryland man’s private safe is a map. But not just any map, mind you… This map shows a “...Banyan Hill Publishing | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredWatch This Robotics Demo Before July 23rdJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... ...Brownstone Research | SponsoredElon’s backup plan for AIElon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredExclusive Offer: Target 100% Returns NowBrace yourself–this may come as a shock. It turns out that you may not have to wait decades to turn a small...ProsperityPub | SponsoredPrepare now for May 31 eventPrepare now for May 31 event Circle May 31 on your calendar This man grew up in a trailer in New Mexico. To...Stansberry Research | SponsoredMemorial Day: 59% dividend from Bitcoin (No Crypto Needed)140% Dividends from stocks like Tesla? Discover How for Just $9! For Memorial Day, get the full details of ...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding SciSparc Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share SciSparc With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy SPRC Stock Free SPRC Stock Alerts